Egyptian Journal of Medical Human Genetics

Table 4 APOE epsilon polymorphism and cardiometabolic risk

From: Association study of APOE gene polymorphisms with diabetes and the main cardiometabolic risk factors, in the Algerian population

APOE ε	ISOR
	APOE3	APOE2	APOE4
T2D
No/yes	455/58	52/6	116/12
OR (95% CI)	1.00 (ref)	0.87 (0.34–2.22)	0.84 (0.42–1.68)
p		0.77	0.63
Obesity
No/yes	414/111	47/20	115/22
OR (95% CI)	1.00 (ref)	1.88 (1.01–3.51)	0.80 (0.48–1.37)
p		0.04	0.41
MetS
No/yes	424/96	48/18	108/28
OR (95% CI)	1.00 (ref)	1.74 (0.92–3.32)	1.29 (0.78–2.14)
p		0.09	0.33
HBP
No/yes	413/112	54/13	110/27
OR (95% CI)	1.00 (ref)	1.18 (0.63–2.20)	0.97 (0.60–1.59)
p		0.60	0.92

T2D type 2 diabetes, MetS metabolic syndrome, HBP high blood pressure. p values were adjusted for age, gender, physical activity, and smoking status. Significant p values are indicated in italics with an asterisk

Back to article page